Menopause Is Having a Moment

For the past few months, you’ve probably been hearing about the turbulence in the bond market.Today, Ben Casselman, the chief economics correspondent for The New York Times, explains what has been happening, and why it matters.Guest: Ben Casselman, the chief economics corresponde ...  Show more

In recent days, Jacob Coxon, a researcher at the artificial intelligence company Anthropic, quit his job and posted warnings about the risks of the technology. That kicked off a crisis that culminated in a call by prominent leaders of the industry to slow down A.I. development.He ...  Show more

Earlier this year the FDA approved a game-changing drug to treat hot flashes, a symptom of menopause. But menopause is much more than just hot flashes, as health writer Jancee Dunn explains. We talked to her in May about why a transition that happens to half the world’s populatio ...  Show more

We've come a long way when it comes to discussing topics in public that used to be considered taboo or referred to as 'women's business', but one issue that is still shunned by society is menopause. Given the obsession with looking and feeling young, it can be difficult for anyon ...  Show more

The FDA approved a game-changing drug to treat hot flashes, a symptom of menopause. Health writer Jancee Dunn talks about why a transition that happens to half the world’s population still feels like a mystery. This episode was produced by Victoria Chamberlin, edited by Amina Al- ...  Show more

During the transition to menopause, approximately 50%-75% of individuals experience vasomotor or genitourinary symptoms. JAMA Senior Editor Linda Brubaker, MD, and Carolyn Crandall MD, MS, of the University of California, Los Angeles, discuss hormonal and nonhormonal therapy f ...